Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Echelon Biosciences in January, 2019 for $150,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM131444-01 | Phase I | 150,000 | January 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Echelon Biosciences in March, 2018 for $1,496,622.0 USD from the U.S. Department of Defense and DARPA. | SBIR | 140D6318C0031 | Phase II | 1,496,622 | March 5, 2018 | |||||||
A SBIR Phase I contract was awarded to Echelon Biosciences in April, 2020 for $167,499.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-20-P-0034 | Phase I | 167,499 | April 3, 2020 | |||||||
A SBIR Phase I contract was awarded to Echelon Biosciences in April, 2017 for $149,592.39 USD from the U.S. Department of Defense. | SBIR | D17PC00157 | Phase I | 149,592.39 | April 17, 2017 | |||||||
A SBIR Phase II contract was awarded to Echelon Biosciences in September, 2014 for $875,580.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44FD004052-02 | Phase II | 875,580 | September 1, 2014 | |||||||
A SBIR Phase II contract was awarded to Echelon Biosciences in November, 2011 for $487,812.0 USD from the National Science Foundation. | SBIR | 1127467 | Phase II | 487,812 | November 1, 2011 | |||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK062522-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $100,110.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM066439-01 | Phase I | 100,110 | ||||||||
A SBIR Phase II contract was awarded to Echelon Biosciences for $548,090.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44AA120001 | Phase II | 548,090 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM065683-01 | Phase I | 100,000 | ||||||||
A STTR Phase II contract was awarded to Echelon Biosciences for $277,549.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42GM086925-02 | Phase II | 277,549 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $149,884.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43FD004052-01 | Phase I | 149,884 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA099434-01 | Phase I | 500,000 | ||||||||
A SBIR Phase II contract was awarded to Echelon Biosciences for $684,906.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM065683-02 | Phase II | 684,906 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $592,461.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI078554-01 | Phase I | 592,461 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $109,120.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI053929-01 | Phase I | 109,120 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM067365-01 | Phase I | 100,000 | ||||||||
A STTR Phase I contract was awarded to Echelon Biosciences for $277,549.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R42GM086925-01 | Phase I | 277,549 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $98,560.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI053048-01 | Phase I | 98,560 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences from the U.S. Department of Health & Human Services. | SBIR | 2R44CA081835-03 | Phase I | 0 | ||||||||
A SBIR Phase II contract was awarded to Echelon Biosciences for $29,261.0 USD from the U.S. Department of Health & Human Services. | SBIR | 275201400007C-2-0-0 | Phase II | 29,261 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $93,749.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS049920-01A2 | Phase I | 93,749 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $599,834.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI077220-01 | Phase I | 599,834 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM084502-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Echelon Biosciences for $200,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA096051-01 | Phase I | 200,000 |